Pfizer's new and recently acquired products generated 22% operational growth in Q1. The company faces a challenging road ...

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

Hantavirus pulmonary infection is a disease caused by some hantaviruses, not the Pfizer-BioNTech COVID-19 vaccine, contrary ...

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Is Pfizer a yield trap? No way.

Veppanu, the first PROTAC therapy approved by the FDA, improved progression free survival by 43% versus AstraZeneca’s ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Pfizer’s $2.3 billion bet on Trillium Therapeutics doesn’t look like it will ever pay out, with the Big Pharma abandoning the ...

Taking a closer look at the numbers, Padcev saw sales tick up 39% to $591 million, which Pfizer chalked up to market share ...

Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close ...

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.